Literature DB >> 12785421

Family history, Hispanic ethnicity, and prostate cancer risk.

S Noell Stone1, Richard M Hoffman, Kristine Tollestrup, Christine A Stidley, Jason L Witter, Frank D Gilliland.   

Abstract

Family history is known to be a prostate cancer (CaP) risk factor for non-Hispanic Whites (NHWs) and African Americans, but little data are available on the risk for Hispanics (Hs). This population-based case-control study used mailed surveys to assess the effects of ethnicity and family history of CaP on CaP risk in Hs and NHWs. Cases (N = 351) were those identified by the New Mexico Tumor Registry as having been newly diagnosed with CaP from October 1, 1994 to October 31, 1995. Controls (N = 618) were randomly selected and frequency-matched to cases by ethnicity and 5-year age groups. Multivariate analyses were conducted using conditional logistic regression. After controlling for age, education, and income in the models, positive family history increased risk for both Hispanics (H) (OR 2.7, 95% CI 1.5-4.7) and non-Hispanic Whites (NHW) (OR 2.0, 95% CI 1.3-3.1), suggesting that having a family history of CaP is a risk factor for both ethnic groups.

Entities:  

Mesh:

Year:  2003        PMID: 12785421

Source DB:  PubMed          Journal:  Ethn Dis        ISSN: 1049-510X            Impact factor:   1.847


  4 in total

Review 1.  A review of cancer in U.S. Hispanic populations.

Authors:  Robert W Haile; Esther M John; A Joan Levine; Victoria K Cortessis; Jennifer B Unger; Melissa Gonzales; Elad Ziv; Patricia Thompson; Donna Spruijt-Metz; Katherine L Tucker; Jonine L Bernstein; Thomas E Rohan; Gloria Y F Ho; Melissa L Bondy; Maria Elena Martinez; Linda Cook; Mariana C Stern; Marcia Cruz Correa; Jonelle Wright; Seth J Schwartz; Lourdes Baezconde-Garbanati; Victoria Blinder; Patricia Miranda; Richard Hayes; George Friedman-Jiménez; Kristine R Monroe; Christopher A Haiman; Brian E Henderson; Duncan C Thomas; Paolo Boffetta
Journal:  Cancer Prev Res (Phila)       Date:  2012-02

2.  Prostate cancer risk prediction in a urology clinic in Mexico.

Authors:  Yuanyuan Liang; Jamie C Messer; Christopher Louden; Miguel A Jimenez-Rios; Ian M Thompson; Hector R Camarena-Reynoso
Journal:  Urol Oncol       Date:  2012-02-03       Impact factor: 3.498

3.  Single and multivariate associations of MSR1, ELAC2, and RNASEL with prostate cancer in an ethnic diverse cohort of men.

Authors:  Joke Beuten; Jonathan A L Gelfond; Jennifer L Franke; Stacey Shook; Teresa L Johnson-Pais; Ian M Thompson; Robin J Leach
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2010-01-19       Impact factor: 4.254

4.  An epidemiological reappraisal of the familial aggregation of prostate cancer: a meta-analysis.

Authors:  Michał Kiciński; Jaco Vangronsveld; Tim S Nawrot
Journal:  PLoS One       Date:  2011-10-31       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.